Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E-Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study

1. Tabernero, J.
2. Grothey, A.
3. Van Cutsem, E.
4. Yaeger, R.
5. Wasan, H.
6. Yoshino, T.
7. Desai, J.
8. Ciardiello, F.
9. Loupakis, F.
10. Hong, Y.S.
11. Steeghs, N.
12. Guren, T.K.
13. Arkenau, H.-T.
14. Garcia-Alfonso, P.
15. Elez, E.
16. Gollerkeri, A.
17. Maharry, K.
18. Christy-Bittel, J.
19. Kopetz, S.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1200/JCO.20.02088 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus